New shot aims to help body fight off lingering hepatitis b
NCT ID NCT07204236
Summary
This early study is testing a new injection called TVAX-008. It aims to see if it can safely boost the body's immune response in people who have chronic Hepatitis B but currently have very low levels of the virus. The study will enroll 20 adults to check if the injection increases protective antibodies and is well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Province Public Health Clinical Center
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.